Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

59459 1490631916HCLSReviewIrelandMarch2017.pdf
Energy Boardroom

Valeant offloads aesthetic treatments to Nestlé's derm unit in $1.4B deal

28.05.2014 / Fierce Pharma

Valeant CEO J. Michael Pearson is an aggressive buyer, especially when it comes to the fast-growing skincare field. But Pearson was also a seller Wednesday, shipping off rights to a handful of cosmetic products to Nestlé as the Swiss food group looks to expand into the dermatology space.

Cover_HCLS_Ireland LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: